Indo Us Bio-Tech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 ,inter alia, to consider and approve the Un-Audited Standalone ....
INDOUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Indo Us Bio-Tech has informed BSE and NSE that its Board of Directors will meet on Friday, 14th November 2025. The main agenda is to consider and approve the Un-Audited Standalone Financial Results for the quarter and half year ended 30th September 2025 (Q2 FY26 and H1 FY26). The filing was made under SEBI LODR Regulations 29 and 33, which require listed companies to give advance notice of board meetings that will consider financial results. No financial figures or other business items are disclosed in this intimation.
This is a routine regulatory intimation with no direct impact on shareholders or the stock price. Investors should await the actual Q2/H1 results announcement on or after 14th November 2025 for any meaningful fundamental update.